<DOC>
	<DOCNO>NCT02078310</DOCNO>
	<brief_summary>A Phase 1b/2 , Randomized , Double-blind , Placebo-Controlled , Multiple Oral Dose Escalation Study Assess Safety , Tolerability Pharmacokinetics ITI-007 Healthy Geriatric Volunteers Geriatric Patients Dementia</brief_summary>
	<brief_title>Study ITI-007 Healthy Geriatric Volunteers Geriatric Patients With Dementia</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<criteria>Part 1 Healthy geriatric volunteer MMSE score &gt; = 26 screen BMI 19.0 40.0 kg/m2 minimum body weight 50 kg screen Part 2 Geriatric patient clinical diagnosis dementia MMSE score &lt; 26 screen BMI 19.0 40.0 kg/m2 minimum body weight 50 kg screen Any clinically significant illness within 6 month screen Any history cancer within last 5 year History Hepatitis B C infection elevate ALT , AST bilirubin upper limit normal level Any subject consider imminent danger others</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Dementia ,</keyword>
	<keyword>Healthy</keyword>
	<keyword>geriatric</keyword>
	<keyword>volunteer</keyword>
	<keyword>patient</keyword>
</DOC>